Global Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Is Set For Rapid Growth, To Reach Around USD 80.95 Billion By 2032

Zion Market Research has published a new report titled “Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market By Type (Embolization Particles and Nanoparticles), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032”. According to the report, the global novel drug delivery systems (NDDS) in cancer therapy market size was valued at approximately USD 15.46 billion in 2023 and is predicted to reach around USD 80.95 billion by the end of 2032, expanding at a CAGR of around 20.2% from 2024 to 2032.

Browse the full “Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market By Type (Embolization Particles and Nanoparticles), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/novel-drug-delivery-systems-in-cancer-therapy-market

The study provides a crucial view on the novel drug delivery systems (NDDS) in cancer therapy by segmenting the market based on type and region. 

Novel drug delivery system (NDDS) refers to formulations, approaches systems and technologies that safely transport drugs or pharmaceutical compounds at specific site in the body to achieve desired therapeutic effects. NDDS incorporates combination of new dosage forms and advance technique which offer better therapeutic profiles over conventional dosage forms. NDDS are widely used across the globe due to various advantages it offers such as optimum dose at specific target site at right time, efficient use of drugs and excipients, improved comfort, low production cost etc. NDSS makes use of embolization particles and nanoparticles. The drug is encapsulated inside the embolization particles and nanoparticles, which protecting the drug from harsh environment and chemical or enzymatic degradation inside the cellular environment. NDSS in cancer therapy focuses on reducing dose administration frequency, minimizing side effects, achieving uniform profile of drug release, and minimizing fluctuating levels of circulating drugs.

Novel drug delivery system (NDDS) in cancer therapy market is witnessing a rapid growth. This growth of the market is driven by various factors such as increasing cancer prevalence across the globe, increasing preference for efficient and novel drug delivery systems that minimize the incidence of adverse events in cancer patients, and increasing cancer awareness. Additionally, increasing R&D investment by major players for novel cancer therapy development, increasing health care spending, favorable reimbursement policies for cancer and upcoming regulatory approvals for new pipeline drugs are important factors that are projected to fuel the market growth. However, high cost of NDDS therapy may impede the market growth over the forecast period. Emerging markets with increasing cancer prevalence and geriatric population are projected to open new growth opportunities for major players in novel drug delivery systems (NDDS) in cancer therapy market.

Based on type, market is segmented into embolization particles and nanoparticles. In 2023, nanoparticles type segment held largest market share. This large share is attributed to their high efficiency. Nanoparticles protect the drug from chemical and enzymatic degradation on exposure to harsh cellular environment by encapsulating the drug. Nanoparticles help improve the pharmacokinetic profile of the drug. Also, drug half-life is increased with the use of nanoparticles and thus longer drug circulation time is achieved. Nanoparticles enhance permeability and have lesser side effects. Thus owing these advantages, nanoparticles are gaining momentum in the market as novel drug delivery system for cancer therapy. Nanoparticles type segment is sub categorized into liposomes, polymers, micelles, and other nanoparticles. On the other hand, embolization particles product type segment is sub-categorized into PVA particles, liquid emboli, drug eluting beads, and other embolization particles. 

North America was dominant regional market in 2023 for global novel drug delivery systems (NDDS) in cancer therapy market. Growing cancer prevalence, increasing number of research projects for novel therapy development, rise in R&D spending availability of advanced R&D infrastructure, increasing promotional activities by manufacturers to create awareness about novel therapies with lesser adverse effects and favorable reimbursement policies are factors driving the market in this region. Europe was second leading regional market for NDDS in cancer therapy market. This is due to faster adoption of novel therapies in developed European countries like Germany, UK, France etc., favorable reimbursement policies for cancer and growing awareness for advanced cancer therapies with minimal adverse effects. Latin America is estimated to be moderately growing region over the forecast period. Asia Pacific region will register rapid growth during the forecast period for novel drug delivery systems (NDDS) in cancer therapy market. Growing cancer prevalence, increasing elderly population, increasing awareness about novel therapies due to promotional activities and increasing healthcare spending are factors likely to promote market growth over the forecast period. Middle East and Africa region is estimated to show considerable growth in coming years.

Major players included in the report are Spectrum Pharmaceuticals, Inc., BTG, Samyang Biopharmaceuticals Corporation, Celgene Corporation, Merrimack Pharmaceuticals, Inc., Shire, Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., and GALEN among others.

The report segment of global novel drug delivery systems (NDDS) in cancer therapy market as follows:

Global Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: By Type

• Embolization Particles
  • PVA Particles
  • Drug Eluting Beads
  • Liquid Emboli
  • Other Embolization Particles
• Nanoparticles
  • Liposomes
  • Polymers
  • Micelles
  • Other nanoparticles

Global Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com